MXPA01003968A - Mutantes de pestivirus y vacunas que contienen los mismos. - Google Patents
Mutantes de pestivirus y vacunas que contienen los mismos.Info
- Publication number
- MXPA01003968A MXPA01003968A MXPA01003968A MXPA01003968A MXPA01003968A MX PA01003968 A MXPA01003968 A MX PA01003968A MX PA01003968 A MXPA01003968 A MX PA01003968A MX PA01003968 A MXPA01003968 A MX PA01003968A MX PA01003968 A MXPA01003968 A MX PA01003968A
- Authority
- MX
- Mexico
- Prior art keywords
- same
- vaccines containing
- mutants
- pestivirus mutants
- pestivirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24364—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201421 | 2000-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01003968A true MXPA01003968A (es) | 2003-08-20 |
Family
ID=8171371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01003968A MXPA01003968A (es) | 2000-04-21 | 2001-04-20 | Mutantes de pestivirus y vacunas que contienen los mismos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US7037508B2 (es) |
EP (1) | EP1149901B1 (es) |
JP (1) | JP4937460B2 (es) |
AT (1) | ATE322541T1 (es) |
BR (1) | BR0101523A (es) |
CA (1) | CA2342305C (es) |
DE (1) | DE60118456T2 (es) |
DK (1) | DK1149901T3 (es) |
ES (1) | ES2261329T3 (es) |
MX (1) | MXPA01003968A (es) |
PT (1) | PT1149901E (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004016794A1 (en) * | 2002-08-13 | 2004-02-26 | Akzo Nobel N.V. | Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
JP2006071631A (ja) * | 2004-08-06 | 2006-03-16 | Bl:Kk | フラビウイルス科ペスチウイルス属ウイルスの検出法およびそのイムノクロマトグラフィーにおける使用 |
US8063195B2 (en) * | 2009-05-22 | 2011-11-22 | The United States Of America As Represented By The Secretary Of Agriculture | Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine |
DK3344289T3 (da) * | 2015-08-31 | 2020-04-14 | Boehringer Ingelheim Vetmedica Gmbh | Pestivirusvacciner mod medfødt tremor |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3757199A (en) * | 1998-04-24 | 1999-11-16 | Washington University | Chimeras of hepatitis c virus and bovine viral diarrhea virus |
EP0965639A1 (en) * | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
-
2001
- 2001-04-17 DE DE2001618456 patent/DE60118456T2/de not_active Expired - Lifetime
- 2001-04-17 AT AT01201388T patent/ATE322541T1/de not_active IP Right Cessation
- 2001-04-17 PT PT01201388T patent/PT1149901E/pt unknown
- 2001-04-17 EP EP01201388A patent/EP1149901B1/en not_active Expired - Lifetime
- 2001-04-17 DK DK01201388T patent/DK1149901T3/da active
- 2001-04-17 ES ES01201388T patent/ES2261329T3/es not_active Expired - Lifetime
- 2001-04-19 BR BR0101523A patent/BR0101523A/pt not_active Application Discontinuation
- 2001-04-19 US US09/839,796 patent/US7037508B2/en not_active Expired - Fee Related
- 2001-04-20 CA CA 2342305 patent/CA2342305C/en not_active Expired - Fee Related
- 2001-04-20 MX MXPA01003968A patent/MXPA01003968A/es active IP Right Grant
- 2001-04-20 JP JP2001122200A patent/JP4937460B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60118456T2 (de) | 2006-08-24 |
CA2342305A1 (en) | 2001-10-21 |
CA2342305C (en) | 2010-11-09 |
JP4937460B2 (ja) | 2012-05-23 |
DK1149901T3 (da) | 2006-07-31 |
PT1149901E (pt) | 2006-08-31 |
BR0101523A (pt) | 2001-11-20 |
JP2002325575A (ja) | 2002-11-12 |
EP1149901B1 (en) | 2006-04-05 |
ATE322541T1 (de) | 2006-04-15 |
DE60118456D1 (de) | 2006-05-18 |
EP1149901A1 (en) | 2001-10-31 |
ES2261329T3 (es) | 2006-11-16 |
US7037508B2 (en) | 2006-05-02 |
US20020086033A1 (en) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU94802A (sh) | 3-prolekovi 2'-deoksi-beta-l-nukleozida | |
DK0386734T3 (da) | Immunogene regioner på E-7-proteinet af humant papillomavirus type 16 | |
DE69936386D1 (de) | Sprühgetrocknete proteinformulierungen | |
IL140217A0 (en) | Particles of hcv envelope proteins: use for vaccination | |
DK1021547T3 (da) | Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf | |
BR9807873A (pt) | Vacinas de flavivìrus quiméricos | |
HK1046403A1 (en) | Nematicidal trifluorobutenes. | |
ES2074950A1 (es) | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. | |
GB2301591A (en) | Cytotoxic T-cell epitopes | |
PT1159968E (pt) | Estirpes atenuadas de vírus do dengue e a sua utilização numa composição de vacina | |
ATE377428T1 (de) | Rotavirus-impfstoff | |
MXPA01003968A (es) | Mutantes de pestivirus y vacunas que contienen los mismos. | |
FI982689A0 (fi) | 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen | |
ATE276761T1 (de) | Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren | |
AU2979899A (en) | Treatment of viral disease in swine | |
ZA90324B (en) | Attentuated viruses | |
ATE112288T1 (de) | Vinylsulfonyl pristinamycine und deren herstellung. | |
IL90743A0 (en) | Non-reverting rna viruses | |
DE60009889D1 (de) | Gipsverzögererzusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |